Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
NASDAQ-listed (FOSL) fashion watch and accessories group with Fossil brand plus Michael Kors and Armani watch licenses; restructuring after Apple Watch compressed the $200-500 fashion smartwatch market.
Fossil Group is a Richardson, Texas-based global accessories brand designing and selling fashion watches, smartwatches, leather goods, and jewelry through its own Fossil brand and licensed designer brands (Michael Kors watches, Armani Exchange watches, Kate Spade watches, Diesel watches, Emporio Armani watches). Listed on NASDAQ (NASDAQ: FOSL), Fossil Group generated $1.5 billion in net sales in fiscal year 2022 (declining from $3.2 billion in 2014 peak) as smartwatch competition and shifting fashion accessories trends challenged its traditional watch business.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.